PTC Inc. is warning of a critical vulnerability in Windchill and FlexPLM, widely used product lifecycle management (PLM) solutions, that could allow remote code execution. The security issue, ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

PTC Industries’ (PTCIL) Q3FY26 EBITDA grew 62% YoY to INR 248mn (-4% YoY) aided by more-than-double sales growth. ATL and TARC registered good top-line growth but margins were under pressure due to ...

PTC Inc. (PTC) delivered impressive first-quarter results for fiscal year 2026, significantly surpassing Wall Street expectations. The company’s earnings per share (EPS) came in at $1.92, a 23.87% ...

DENVER (KDVR) — The Colorado Department of Revenue revealed on Wednesday how much eligible Coloradans can receive through its PTC Rebate Program and unveiled a new tax credit for Coloradans with ...

San Diego-based Tang Capital Management added 400,000 PTC Therapeutics shares in the third quarter. The value of the position increased by $38.3 million quarter over quarter. Tang Capital reported ...

PTC isn't receiving much help from macroeconomic conditions, but its key metric is still growing strongly as it adds tangible value. Infusing AI into its software will enhance the efficacy of the ...

AI-driven generative design automates the exploration of thousands of design permutations, significantly reducing development cycles and costs. Integration of simulation and manufacturing constraints ...

Seth MacFarlane once famously called the PTC "like getting hate mail from Hitler." Now they've filed for Chapter 11. By James Hibberd Writer-at-Large The organization’s tagline was “Because Our ...

The U.S. Food and Drug Administration has turned away PTC Therapeutics' proposed vatiquinone treatment for the rare, inherited neurodegenerative disorder Friedreich's ataxia over concerns about the ...